Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

FEMYSO

LUPIN PHARMA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of FEMYSO in Canada?

A shortage of FEMYSO 200MCG 200MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 28, 2026), but it has not started yet.

Why is FEMYSO not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will FEMYSO be available again?

The manufacturer's estimated resolution date is October 12, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusAnticipated Shortage
Same-ingredient products on fileNone found
Expected resolution~7 days remaining (estimate)
Affected strength200MCG 200MG
Last updated2026-09-28

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

Estimated Resolution

2026-10-12

~7 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

DIN

02560569

Strength

200MCG 200MG

Dosage Form

TABLET KIT

Route

BUCCAL ORAL

Active Ingredient

MISOPROSTOL MIFEPRISTONE

Tier

Unrated

Last Updated

2026-09-28

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

FEMYSO has 2 shortage/discontinuation reports on file — this is one of them.